Genomma Lab InternacionalB de CV (MEX:LABB) 3-Year Revenue Growth Rate : 7.90% (As of Mar. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Genomma Lab InternacionalB de CV 3-Year Revenue Growth Rate?

Genomma Lab InternacionalB de CV's Revenue per Share for the three months ended in Mar. 2024 was MXN4.06.

During the past 12 months, Genomma Lab InternacionalB de CV's average Revenue per Share Growth Rate was -0.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was 7.90% per year. During the past 5 years, the average Revenue per Share Growth Rate was 9.00% per year. During the past 10 years, the average Revenue per Share Growth Rate was 5.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Genomma Lab InternacionalB de CV was 56.30% per year. The lowest was 2.10% per year. And the median was 10.30% per year.

Competitive Comparison of Genomma Lab InternacionalB de CV's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Genomma Lab InternacionalB de CV's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genomma Lab InternacionalB de CV's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Genomma Lab InternacionalB de CV's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Genomma Lab InternacionalB de CV's 3-Year Revenue Growth Rate falls into.

Genomma Lab InternacionalB de CV 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Genomma Lab InternacionalB de CV (MEX:LABB) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Genomma Lab InternacionalB de CV 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Genomma Lab InternacionalB de CV's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Genomma Lab InternacionalB de CV (MEX:LABB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Genomma Lab Internacional SAB de CV (MEX:LABB) » Definitions » 3-Year Revenue Growth Rate

Traded in Other Exchanges

GNMLF:USA GEKA:Germany

Address

Avenida Antonio Dovalí Jaime, Number 70, Tower C, Floor 2, Office A. Colonia Santa Fe, Del. Alvaro Obregon, Mexico, MEX, MEX, CP 01210

Website

https://www.genommalab.com

Genomma Lab Internacional SAB de CV is a specialty and generic drug manufacturer. The company's stated goal is to improve and preserve the health and well-being of people through innovative, safe, and effective products. Genomma operates a wide variety of brands to serve different consumer needs, including pregnancy, pain medication, and deodorant. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Genomma Lab InternacionalB de CV (MEX:LABB) Headlines

No Headlines